# Impulse Monitoring

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/impulse-monitoring

- Industry: Healthcare Specialists
- Headquarters: Columbia, US
- Website: www.impulsemonitoring.com
- Total disclosed funding: $14M
- Latest round: Series B (Jan 31, 2007)
- Investors on record: 2

## About

Impulse Monitoring Inc. specializes in intraoperative neuromonitoring (IONM), delivering essential services that safeguard patients during surgeries through real-time monitoring of nervous system integrity.Impulse Monitoring Inc. was founded in 2002 in Columbia, US, focusing on intraoperative neuromonitoring. The company was acquired by NuVasive in October 2011 for USD 80 mn, which indicates a strategic pivot in its operational capacity. The total number of deals reported is 3, reflecting a concentrated growth strategy under NuVasive's leadership.Impulse Monitoring Inc. provides NuVasive Clinical Services, which focuses on intraoperative neuromonitoring (IONM). Their offerings include various monitoring techniques like somatosensory evoked potentials (SSEP), electromyography (EMG), and brainstem auditory evoked responses (BAER), ensuring the protection of patients during surgical procedures. The company is involved in over 100,000 cases annually in the United States, maintaining high standards of service as evidenced by its accreditation from The Joint Commission.Impulse Monitoring Inc. generates revenue primarily through B2B transactions with healthcare facilities and surgical centers utilizing its IONM services. Revenue is derived from service contracts that typically incorporate fixed fees and variable costs according to the complexity of the monitoring required. This revenue model is sustained by ongoing partnerships with healthcare providers, establishing a steady demand for its critical services.Following the acquisition by NuVasive in October 2011, for USD 80 mn, Impulse Monitoring Inc. plans to expand its market presence by enhancing product offerings in the intraoperative monitoring space. There are no specific upcoming product launches mentioned, but the company aims to leverage NuVasive's resources for geographic expansion into new healthcare markets in the US and internationally, targeting a broader clientele by enhancing its operational capabilities over the coming years.

## Funding rounds

- Series B, Jan 31, 2007, $4.5M — Tullis Health Investors, Ascension Ventures
- Series A, Jun 6, 2006, $9M — Tullis Health Investors

## Investors

- Tullis Health Investors (https://capitalatlas.ai/funds/tullis-health-investors) — Series A, Series B
- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series B